SC
PROK icon

SummitTX Capital’s ProKidney PROK Stock Holding History

SummitTX Capital’s Portfolio PROK Stock Details PROK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$26.1K Buy
+14,600
New +$31K ﹤0.01% 737

Other funds holding PROK

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
AGP
Artia Global Partners Miami, Florida $499M AUM 186.05% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

SummitTX Capital's PROK Position: Q1 2026 in Review

SummitTX Capital opened a new position in ProKidney (PROK) in Q1 2026: 14,600 shares worth $26.1K. The stake represents ﹤0.01% of the portfolio and ranks #737 among its holdings.

71 funds tracked by Wall St. Rank hold PROK as of Q1 2026.

  • SummitTX Capital held 14,600 shares of ProKidney worth $26.1K as of Q1 2026.
  • ProKidney was a new SummitTX Capital position in Q1 2026.
  • ProKidney made up ﹤0.01% of SummitTX Capital's portfolio in Q1 2026, its #737 holding.
  • 71 funds tracked by Wall St. Rank held ProKidney as of Q1 2026.

Based on SummitTX Capital's 13F filing for Q1 2026, filed 15 May 2026.